BSACI COVID-19 Resources

In the face of a major shift in practice due to COVID-19, it is vital for specialist allergy and immunology services to develop a robust local strategy that will allow provision of services to patients with allergic and immunological conditions in a safe and effective manner, making efficient use of the limited resources we have, while protecting the health of patients and staff. As a result we have been working on this ‘Service Recovery Document’ document which outlines some general principles which may be helpful in developing ways to achieve this locally, taking into account the complex nature of specialist service provision.
The Management of Anaphylaxis in a vaccination setting
BSACI in conjunction with the Resuscitation Council UK, the RCGP and Public Health England, have produced updated information for use in any vaccination setting to give clear guidance to healthcare professionals involved. Click here to view this. There is also poster of the algorithm for the management of anaphylaxis in the vaccination setting.
Herewith a collated list of adult drug allergy clinics from the BSACI allergy service finder.
A survey was distributed by IQAS and QPIDS, to assess the impact of the COVID-19 pandemic on allergy and immunology services. The responses came from all around the country and are below for each service. BSACI would like to thank Andrew Whyte and in particular Professor M. Thirumala Krishna (IQAS Clinical Lead), Dr Claire Bethune (QPIDS Clinical Lead), and the RCP team for coordinating the survey and collating the results.
Adult Immunology Survey results
Allergy In the Post COVID-19 World Webinar 2, Monday 29th June
Allergy In the Post COVID-19 World webinar 1 Monday 1st June
MODIFICATIONS FOR ADULT ALLERGY SERVICES DURING COVID-19 PANDEMIC
MODIFICATIONS FOR PAEDIATRIC ALLERGY SERVICES DURING COVID-19 PANDEMIC
Allergy in ICD-11 NL12 Newsletter
RCPsych – Top ten messages for supporting healthcare staff during the COVID – 19 Pandemic
BAD Guidance for Managing Urticaria Patients on Omalizumab during the Coronavirus Pandemic.
BAD – Dermatology Advice Regarding Immunosuppressed Patients: Adults, Paediatrics and Young People
RCPCH Guidance and updates on COVID-19
RCP (London) developments and guidance
Latest COVID-19 guidance from the RCGP
British Association of Dermatologists
British Society of Gastroenterology
Coronavirus and Allergies – Frequently asked Questions & Answers (updated 15.01.21)
Support from the BSACI Nurses group to BSACI nursing members